Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients

Journal of Medical Virology

Volumn 76, Issue 3, 2005, Pages 367-372

  Piiparinen, H ^a   Helantera I ^a   Lappalainen, M ^a   Suni, J ^a   Koskinen, P ^a   Gronhagen Riska C ^a   Lautenschlager, I ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

CMV; Quantitative PCR; Renal transplantation

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GANCICLOVIR; VIRUS DNA;

ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC KIT; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LEUKOCYTE; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT MONITORING; POLYMERASE CHAIN REACTION; SHELL VIAL CULTURE; VIRUS CULTURE; VIRUS LOAD;

ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FINLAND; GANCICLOVIR; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; STATISTICS; VIRAL LOAD; VIRUS CULTIVATION;

EID: 20044375389     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20367     Document Type: Article

References (24)

1. Aitken C, Barrett-Muir W, Millar C, 1999. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J Clin Microbiol 37:2804-2807.
2. Boeckh M, Boivin G. 1998. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 11:5333-5344.
3. Caliendo A, St George K, Kao S, et al. 2000. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: Clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol 38:2122-2127.
4. Emery VC, Cope AV, Bowen EF, et al. 1999. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 190:177-182.
5. Fishman JA, Rubin RH. 1998. Infection in organ-transplant recipients. N Engl J Med 338:1741-1751.
6. Flexman J, Kay I, Fonte R, et al. 2001. Differences between quantitative antigenemia assay and the Cobas Amplicor Monitor quantitative PCR assay for detecting CMV viremia in bone marrow and solid organ transplant patients. J Med Virol 64:275-282.
7. Gerna G, Percivalle E, Torcellini M, et al. 1998. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro generated pp65 positive peripheral blood polymorphonuclear leukocytes. J Clin Microbiol 36:3585-3589.
8. Halwachs-Bauman G, Wilders-Trusching M, Enzinger G, et al. 2001. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: The impact of molecular assays. J Clin Virol 20:49-57.
9. Humar A, Gregson D, Caliendo AM, et al. 1999. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 68:1305-1311.
10. Lautenschlager I, Suni J, Ahonen J, et al. 1989. Detection of cytomegalovirus (CMV) by early antigen immunofluorescence test and by conventional tissue culture. Eur J Microbiol Infect Dis 8:610-613.
11. Li H, Dummer JS, Estes WR, et al. 2003. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 41:187-191.
12. Mengelle C, Pasquier C, Rostaing L, et al. 2003. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Med Virol 69:225-231.
13. Patel R, Paya CV. 1998. Cytomegalovirus infection and disease in solid organ transplant recipients. In: Bowden RA, Ljungman P, Paya CV, editors. Transplant infections. Philadelphia: Lippincott-Raven Publishers. pp 229-244.
14. Piiparinen H, Höckerstedt K, Grönhagen-Riska C, et al. 2001. Comparison of plasma polymerase chain reaction and pp65 antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients. J Clin Virol 22:111-116.
15. Piiparinen H, Höckerstedt K, Lappalainen M, et al. 2002. Monitoring of viral load by quantitative plasma PCR during active CMV infection of individual liver transplant patients. J Clin Microbiol 38:4485-4491.
16. Razonable RR, Brown RA, Espy MJ, et al. 2001. Comparative quantitation of cytomegalovirus (CMV) DANA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems. J Clin Microbiol 39:4472-4476.
17. Roberts TC, Brennan DC, Buller RS, et al. 1998. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and asses response to ganciclovir therapy in renal transplant recipients. J Infect Dis 178:626-635.
18. Rollag H, Sagedal S, Kristiansen KI, et al. 2002. Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients. Clin Microbiol Infect 7:431-434.
19. Schaade L, Kockelkorn P, Ritter K, et al. 2000. Detection of cytomegalovirus DNA in human specimens by Light Cycler PCR. J Clin Microbiol 38:4006-4009.
20. Sia IG, Wilson JA, Espy MJ, et al. 2000. Evaluation of the COBAS AMPLICOR CMV MONITOR test for the detection of viral DNA in specimens taken from patients after liver transplantation. J Clin Microbiol 38:600-606.
21. Tong CY, Cuevas LE, Williams H, et al. 2000. Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation. J Clin Microbiol 38:1209-1213.
22. Toyada M, Carlos JB, Galera OA, et al. 1997. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients. Transplantation 63:957-963.
23. Van der Berg AP, van der Bij W, van Son WJ, Anema J, et al. 1989. Cytomegalovirus-antigenemia as a useful marker of symptomatic cytomegalovirus disease after renal transplantation: A report of 130 consecutive patients. Transplantation 48:991-995.
24. Verschuuren EAM, Harmsen MC, Limburg PC, et al. 1999. The Biomed 2 Study Goup. Towards standardization of the human cytomegalovirus antigenemia assay. Intervirology 42:382-389.